Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon Licenses Roche Reagent for PCR Assays

NEW YORK (GenomeWeb News) – Danish gene expression company Exiqon has licensed real-time PCR-related technology from Roche Diagnostics, Roche said today.
Under the agreement, Roche has granted Exiqon a non-exclusive license to use the SYBR Green reagent for detecting and quantitating PCR products in real-time PCR reactions.
Roche also noted that the two companies recently amended a 2005 license and distribution agreement allowing Roche to sell Exiqon’s Universal ProbeLibrary products.
Financial terms of the agreement were not released.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.